We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ASXC market cap is 88.62M. The company's latest EPS is USD -0.2880 and P/E is -1.15.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.46M | 976k | 1.08M | 1.09M | 5.43M |
| Operating Income | -16.64M | -22.24M | -20.97M | -19.59M | -16.67M |
| Net Income | -17.89M | -22.22M | -20.66M | -18.32M | -17.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.08M | 3.18M | 8.23M | 7.09M | 8.58M |
| Operating Income | -170.44M | -60.39M | -66.18M | -75.36M | -79.47M |
| Net Income | -154.2M | -60.02M | -62.46M | -75.56M | -78.43M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 116.05M | 96.52M | 78.37M | 70.73M | 59.09M |
| Total Liabilities | 16.41M | 16.81M | 16.87M | 23.47M | 25.67M |
| Total Equity | 99.65M | 79.72M | 61.5M | 47.25M | 33.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 74.78M | 78.26M | 186.47M | 116.05M | 59.09M |
| Total Liabilities | 19.24M | 16.69M | 17.23M | 16.41M | 25.67M |
| Total Equity | 55.54M | 61.57M | 169.25M | 99.65M | 33.41M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -58.94M | -17.25M | -35.2M | -50.25M | -63.63M |
| Investing | 47.54M | 29.74M | 36.3M | 57.08M | 64.51M |
| Financing | -332k | -483k | -289k | 9.45M | 9.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -73.48M | -46.68M | -40.66M | -58.94M | -63.63M |
| Investing | 67.65M | -3k | -119.67M | 47.54M | 64.51M |
| Financing | -5.61M | 53.37M | 161.71M | -332k | 9.63M |
| Market Cap | 88.62M |
| Price to Earnings Ratio | -1.15 |
| Price to Sales Ratio | 10.48 |
| Price to Cash Ratio | 5.25 |
| Price to Book Ratio | 2.69 |
| Dividend Yield | - |
| Shares Outstanding | 272.33M |
| Average Volume (1 week) | 3.12M |
| Average Volume (1 Month) | 4.2M |
| 52 Week Change | -34.92% |
| 52 Week High | 0.6469 |
| 52 Week Low | 0.204 |
| Spread (Intraday) | 0 (1.06%) |
| Company Name | Asensus Surgical Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.transenterix.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
